|
|
TheraVitae is a global leader in adult stem cell research and treatment. Our therapies give patients with no other options a second chance. By using the patient’s own stem cells to heal him, our treatments can reverse the effects of debilitating degenerative diseases.
We are committed to helping people live fuller, healthier lives. Our mission is to develop and commercialize adult stem cell therapies to treat previously incurable diseases. VesCell™, our lead product, has been used to successfully treat more than three hundred patients suffering from heart disease and peripheral artery disease.
Our patented process has undergone clinical trials in Thailand, is currently undergoing trials in Hungary, and we are developing similar studies for North America with the eventual goal of attaining FDA approval. Once approved for use in the U.S., these lifesaving treatments will become widely available to patients at a price comparable to that of medicated stents.
|